Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Excessive variability in the performance and interpretation of the metacholine bronchial challenge test.

Martínez Moragón E, Pérez de Llano L, Perpiñá M.

Arch Bronconeumol. 2016 Nov;52(11):574. doi: 10.1016/j.arbres.2016.05.001. Epub 2016 Jun 16. English, Spanish. No abstract available.

2.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

3.

Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.

Barnes N, van Noord JA, Brindicci C, Lindemann L, Varoli G, Perpiña M, Guastalla D, Casula D, Patel S, Chanez P; FACTO (Foster® As Complete Treatment Option) Study Group.

Pulm Pharmacol Ther. 2013 Oct;26(5):555-61. doi: 10.1016/j.pupt.2013.01.011. Epub 2013 Mar 22.

PMID:
23524015
4.

Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia.

Moret I, Lorenzo MJ, Sarria B, Cases E, Morcillo E, Perpiñá M, Molina JM, Menéndez R.

Eur Respir J. 2011 Nov;38(5):1158-64. doi: 10.1183/09031936.00190410. Epub 2011 Mar 24.

5.

[Inflammatory response of rapid onset asthma exacerbation].

Bellido-Casado J, Plaza V, Perpiñá M, Picado C, Bardagí S, Martínez-Brú C, Torrejón M.

Arch Bronconeumol. 2010 Nov;46(11):587-93. doi: 10.1016/j.arbres.2010.07.002. Epub 2010 Sep 15. Spanish.

6.

Latex: a hidden occupational allergen.

Añíbarro B, Seoane FJ, Perpińá MA, Carnés J.

Ann Allergy Asthma Immunol. 2010 Jan;104(1):94-5. No abstract available.

PMID:
20143653
7.

Relationship between the characteristics of hospitalised acute asthma patients and the severity of their asthma. A case-control study.

Rodrigo GJ, Plaza V, Neffen H, Levy G, Perpiñá M.

Allergol Immunopathol (Madr). 2009 Sep-Oct;37(5):225-9. doi: 10.1016/j.aller.2009.03.008. Epub 2009 Sep 23.

PMID:
19775803
8.

[Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].

Plaza V, Bellido-Casado J, Rodrigo GJ, Solarte I, Rodríguez-Trigo G, Sepúlveda R, Neffen H, Perpiñá M.

Arch Bronconeumol. 2009 Nov;45(11):545-9. doi: 10.1016/j.arbres.2009.05.009. Epub 2009 Aug 3. Spanish. Erratum in: Arch Bronconeumol. 2010 Aug;46(8):451. Solarte, Javier [corrected to Solarte, Iván].

9.

[Perception of dyspnea and treatment adherence in asthmatic patients].

Martínez-Moragón E, Perpiñá M, Fullana J, Macián V, Lloris A, Belloch A.

Arch Bronconeumol. 2008 Sep;44(9):459-63. Spanish.

10.

[Does experience influence perception of dyspnea?].

Martínez-Moragón E, Perpiñá M, Belloch A.

Arch Bronconeumol. 2006 Apr;42(4):171-4. Spanish.

11.

[Evolution over time in over perceivers of dyspnea in asthma].

Martínez-Moragón E, Perpiñá M, Belloch A, Serra B, Lloris A, Macián V.

Arch Bronconeumol. 2006 Mar;42(3):120-4. Spanish.

12.

Airway inflammation and cough sensitivity in cough-variant asthma.

De Diego A, Martínez E, Perpiñá M, Nieto L, Compte L, Macián V, Senent L.

Allergy. 2005 Nov;60(11):1407-11.

PMID:
16197473
13.

[Agreement in asthmatics' perception of dyspnea during acute and chronic obstruction].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2005 Jul;41(7):371-5. Spanish.

14.

[Prevalence of hyperventilation syndrome in patients treated for asthma in a pulmonology clinic].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A.

Arch Bronconeumol. 2005 May;41(5):267-71. Spanish.

15.

[Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease].

Soler JJ, Sánchez L, Román P, Martínez MA, Perpiñá M.

Arch Bronconeumol. 2004 Jun;40(6):250-8. Spanish.

16.

Risk factors of emergency care and admissions in COPD patients with high consumption of health resources.

Soler JJ, Sánchez L, Román P, Martínez MA, Perpiñá M.

Respir Med. 2004 Apr;98(4):318-29.

17.

Gender differences in health-related quality of life among patients with asthma.

Belloch A, Perpiñá M, Martínez-Moragón E, de Diego A, Martínez-Francés M.

J Asthma. 2003 Dec;40(8):945-53.

PMID:
14736095
18.

Duration of length of stay in pneumonia: influence of clinical factors and hospital type.

Menéndez R, Cremades MJ, Martínez-Moragón E, Soler JJ, Reyes S, Perpiñá M.

Eur Respir J. 2003 Oct;22(4):643-8.

19.

Determinants of dyspnea in patients with different grades of stable asthma.

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés M.

J Asthma. 2003 Jun;40(4):375-82.

PMID:
12870833
20.

Evaluation of nonresolving and progressive pneumonia.

Menéndez R, Perpiñá M, Torres A.

Semin Respir Infect. 2003 Jun;18(2):103-11. Review.

PMID:
12840791
21.

[Efficacy of an antibacterial filter for preventing contamination of respiratory function diagnostic equipment].

Macián V, Compte L, Perpiñá M, Ferrando D, Cercos A, Lloris A, Martínez M.

Arch Bronconeumol. 2003 Jun;39(6):261-5. Spanish.

22.

Cough reflex testing with inhaled capsaicin in the study of chronic cough.

Nieto L, de Diego A, Perpiñá M, Compte L, Garrigues V, Martínez E, Ponce J.

Respir Med. 2003 Apr;97(4):393-400.

23.

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370.

24.

[Asthma patients' perception of dyspnea during acute bronchoconstriction].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2003 Feb;39(2):67-73. Spanish.

25.

Noninvasive positive pressure home ventilation in restrictive disorders: outcome and impact on health-related quality of life.

Nauffal D, Doménech R, Martínez García MA, Compte L, Macián V, Perpiñá M.

Respir Med. 2002 Oct;96(10):777-83.

26.

[Perception of improvement in asthma patients].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2002 Oct;38(10):468-72. Spanish.

27.

[Analysis of the impact of Archivos de Bronconeumología through the Science Citation Index].

García F, Mayoralas S, Dorgham A, Granda I, Perpiñá M, Casan P, Xaubet A, Agustí AG, Alvarez-Sala JL.

Arch Bronconeumol. 2001 Dec;37(11):465-70. Spanish.

28.

[The impact of COPD on hospital resources: the specific burden of COPD patients with high rates of hospitalization].

Soler J, Sánchez L, Latorre M, Alamar J, Román P, Perpiñá M.

Arch Bronconeumol. 2001 Oct;37(9):375-81. Spanish.

29.

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.

Zetterström O, Buhl R, Mellem H, Perpiñá M, Hedman J, O'Neill S, Ekström T.

Eur Respir J. 2001 Aug;18(2):262-8.

30.

Initial risk class and length of hospital stay in community-acquired pneumonia.

Menéndez R, Ferrando D, Vallés JM, Martínez E, Perpiñá M.

Eur Respir J. 2001 Jul;18(1):151-6.

31.

[Gain, loss and agreement between respiratory specialists and generalists in the diagnosis of asthma].

Pellicer C, Ramírez R, Perpiñá M, Cremades M, Fullana J, García I, Gilabert M.

Arch Bronconeumol. 2001 Apr;37(4):171-6. Spanish.

32.

[Clinical manifestations and prevalence of hypercoagulable states in patients with venous thromboembolic disease].

Briones A, Nauffal D, Villa P, Angel Martínez M, Menéndez R, Perpiñá M.

Med Clin (Barc). 2001 Feb 17;116(6):201-5. Spanish.

PMID:
11333716
33.

Prevalence of gastroesophageal reflux in asthma.

Compte L, Garrigues V, Perpiña M, Ponce J.

J Asthma. 2000 Apr;37(2):175-82.

PMID:
10805206
34.

[The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 2000 Feb;36(2):90-4. Spanish.

35.

[20210G/A mutation of prothrombin gene in a patient with deep venous thrombosis ad pulmonary embolism without other risk factors of thrombosis].

de la Cuadra P, Nauffal MD, Vayá Montaña A, Martínez MA, Perpiñá M.

Arch Bronconeumol. 1999 Dec;35(11):567-70. Spanish.

PMID:
10687043
36.

[Information seeking and decision making in asthmatic patients].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 1999 Oct;35(9):435-9. Spanish.

PMID:
10596340
37.

[Descriptive study of patients diagnosed with asthma in a regional respiratory medicine practice].

Pellicer C, Lorente P, Valero P, Cremades MJ, Fullana J, Perpiñà M, Gilabert MJ, García Peiró I.

Arch Bronconeumol. 1999 Apr;35(4):167-72. Spanish.

PMID:
10330537
38.

[Prognostic features of residual pleural thickening in metapneumonic pleural effusion].

Martínez MA, Cordero PJ, Cases E, Sanchis JL, Sanchis F, Ferrando D, Perpiñá M.

Arch Bronconeumol. 1999 Mar;35(3):108-12. Spanish.

PMID:
10216741
39.

Assessment of the reliability, validity, and responsiveness of a Spanish Asthma Quality of Life questionnaire.

Perpiñá M, Belloch A, Marks GB, Martinez-Moragón E, Pascual LM, Compte L.

J Asthma. 1998;35(6):513-21.

PMID:
9751069
40.

[Factors related to diagnostic reliability of bronchial biopsy in primary bronchogenic carcinoma].

Greses JV, Soler JJ, Perpiñá M, Sanchís J, Vera F.

Arch Bronconeumol. 1997 Dec;33(11):556-60. Spanish.

PMID:
9580039
41.

Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes.

Villagrasa V, Berto L, Cortijo J, Perpina M, Sanz C, Morcillo EJ.

Gen Pharmacol. 1997 Oct;29(4):605-9.

PMID:
9352310
42.

[The quality of life related to health in pneumology].

Güell R, Perpiñá M.

Arch Bronconeumol. 1997 May;33(5):257-8. Spanish. No abstract available.

PMID:
9254176
43.

[Treatment of asthmatic crises at a hospital emergency service. Are the protocols followed?].

Rogado MC, de Diego A, de la Cuadra P, Perpiñá M, Compte L, León M.

Arch Bronconeumol. 1997 Apr;33(4):179-84. Spanish.

PMID:
9280560
44.

[Reliability of the presurgical anatomopathologic diagnosis in primary bronchogenic carcinoma].

Soler JJ, Perpiñá M, Greses JV, Calvo V, Padilla J, París F.

Med Clin (Barc). 1997 Jan 25;108(3):81-6. Spanish.

PMID:
9064436
45.

Subjective symptomatology of asthma: validation of the asthma symptom checklist in an outpatient Spanish population.

Belloch A, Perpiñá MJ, Pascual LM, Martinez M, De Diego A.

J Asthma. 1997;34(6):509-19.

PMID:
9428297
46.

Disseminated pulmonary granulomas after intravesical bacillus Calmette-Guérin immunotherapy.

De Diego A, Rogado MC, Prieto M, Nauffal D, Perpiñá M.

Respiration. 1997;64(4):304-6.

PMID:
9257368
47.

The Revised Asthma Problem Behavior Checklist: adaptation for use in Spanish asthmatic patients.

Belloch A, Perpiñá M, Pascual LM, de Diego A, Creer TL.

J Asthma. 1997;34(1):31-41.

PMID:
9033438
48.

[Profile of a pneumology regional health service].

Pellicer C, Fullana J, Cremades MJ, Rivera ML, Perpiñà M.

Arch Bronconeumol. 1996 Nov;32(9):447-52. Spanish.

PMID:
9064082
49.

Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.

Villagrasa V, Navarrete C, Sanz C, Berto L, Perpiñá M, Cortijo J, Morcillo EJ.

Methods Find Exp Clin Pharmacol. 1996 May;18(4):239-45.

PMID:
8803956
50.

Cell type accuracy of bronchial biopsy specimens in primary lung cancer.

Cataluña JJ, Perpiñá M, Greses JV, Calvo V, Padilla JD, París F.

Chest. 1996 May;109(5):1199-203.

PMID:
8625667

Supplemental Content

Loading ...
Support Center